| 000 | 01359 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511220946.0 | ||
| 264 | 0 | _c19910712 | |
| 008 | 199107s 0 0 eng d | ||
| 022 | _a0002-9378 | ||
| 024 | 7 |
_a10.1016/0002-9378(91)91424-u _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurkman, R T | |
| 245 | 0 | 0 |
_aOral contraceptives and antithrombin III: variations by dosage and ABO blood group. _h[electronic resource] |
| 260 |
_bAmerican journal of obstetrics and gynecology _cJun 1991 |
||
| 300 |
_a1453-8; discussion 1458-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aABO Blood-Group System |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntithrombin III _xanalysis |
| 650 | 0 | 4 |
_aContraceptives, Oral _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEthinyl Estradiol _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunologic Techniques |
| 650 | 0 | 4 |
_aNorethindrone _xpharmacology |
| 700 | 1 | _aBell, W R | |
| 700 | 1 | _aZacur, H A | |
| 700 | 1 | _aKimball, A W | |
| 773 | 0 |
_tAmerican journal of obstetrics and gynecology _gvol. 164 _gno. 6 Pt 1 _gp. 1453-8; discussion 1458-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9378(91)91424-u _zAvailable from publisher's website |
| 999 |
_c2054773 _d2054773 |
||